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Severe ulcerous cytomegalovirus pancolitis developed during
primary human immunodeficiency virus (HIV) infection in
a patient who underwent early combination antiretroviral
treatment. This massive inflammatory process led to acute
colon perforation. Serological testing demonstrated cyto-
megalovirus reactivation. Severe immunosuppression caused
by primary HIV infection resulted in cytomegalovirus colitis,
and initiation of early combination antiretroviral therapy
triggered an immune reconstitution inflammatory syndrome
potentially leading to colonic perforation.
Acute retroviral syndrome is defined by unspecific symptoms
that can vary greatly, and it occurs in 40%–90% of HIV-infected
individuals [1, 2]. On rare occasions, opportunistic infections
present simultaneously with acute retroviral syndrome [1], and
only 2 reports mentioning acute cytomegalovirus (CMV) dis-
ease in primary HIV infection were found in the literature [3,
4]. To date, no case of immune reconstitution inflammatory
syndrome during primary HIV infection has been reported.
CMV is one of the most common causes of opportunistic
infections in persons with AIDS, and clinical CMV disease has
been reported in up to 40% of these patients [5, 6]. Similar to
other common herpesvirus infections in HIV-infected patients,
CMV disease almost exclusively occurs as a result of reactivation
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of the latent virus in a previously infected host. Clinically man-
ifested CMV disease in HIV-infected patients usually presents
in severely immunocompromised patients with CD4 cell counts
!100 cells/mL, with 85% of patients showing retinitis. Esoph-
agitis and colitis have been observed in 2.7% and 7.3% of these
patients, respectively [6, 7]. Colitis is the most common ex-
traocular manifestation of CMV disease in HIV-infected pa-
tients, although only a few anecdotal reports of CMV colitis
in immunocompetent hosts are found in the literature [8, 9].
Most patients with CMV colitis present with diarrhea, abdom-
inal pain, fever, weight loss, and cachexia. Extensive gastroin-
testinal hemorrhage and perforation have also been reported.
Case report. A 40-year-old man who had sex with men
presented in July 2005 at our tertiary care hospital with a 3-
week history of weight loss, frequent diarrhea, nausea, and
vomiting, accompanied by fevers and oral candidiasis. Fur-
thermore, the patient reported having had flu-like symptoms
without exanthema for 7 days. Clinical examination revealed
tachycardia, tachypnea, a temperature of 38.3C, and diffuse
abdominal pain, combined with massive pain on rectal ex-
amination. Initial blood counts revealed anemia (hemoglobin
level, 10.6 g/dL), leukocytosis (leukocyte count, leu-311.66 10
kocytes/mL), and a massively elevated C-reactive protein level
(387 mg/L). The result of an HIV screening test was positive,
and a subsequent Western blot assay confirmed the result. The
result of a p24 antigen test was negative, the patient’s plasma
HIV RNA level was 3,080,000 copies/mL, and his CD4 cell
count was 164 cells/mL (with 22% neutrophils). Primary HIV
infection was suspected on the basis of clinical findings at pre-
sentation, anamnestic sexual risk exposure, and a previous neg-
ative HIV test result (in July 2004) and was later confirmed by
an anti-gp120 avidity assay [10]. Following initiation of early
antiretroviral treatment (ART; lopinavir plus ritonavir, zido-
vudine, and lamivudine) and cotrimoxazole prophylaxis, the
patient’s clinical condition aggravated, and colonoscopy and
subsequent biopsy findings led to the diagnosis of a severe,
ulcerous acute colitis. The patient began to receive empirical
intravenous antibiotic therapy with ciprofloxacin and amox-
cicillin–clavulanic acid; later, therapy was switched to cipro-
floxacin and metronidazol. Antibiotic therapy was stopped after
numerous tests yielded results negative for diverse bacterial,
viral, and parasitic pathogens. During the following days, the
patient improved clinically. Twenty days after hospital admis-
sion and 14 days after initiation of early combination ART, he
suddenly developed high fevers, combined with an acute ab-
domen and elevated inflammation parameters. Abdominal CT
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Figure 1. A, Abdominal CT showing a pneumoperitoneum indicating perforation of the colon. B, Hematoxylin-eosin stain revealing severe ulcerous
colitis (original magnification, 15). C, Hematoxylin-eosin stain revealing ulcerous colitis with acute inflammation and granulation tissue (original
magnification, 40). D, Immunohistochemical stain for detection of immediate early antigen and early antigen, revealing cells with cytomegalic
inclusions (original magnification, 200).
showed a pneumoperitoneum, indicating perforation of the
colon (figure 1A), and the patient underwent emergency sub-
total colectomy. Histopathological examination revealed severe
ulcerous colitis with acute inflammation and granulation tissue
on hematoxylin-eosin staining (figure 1B and 1C). Subsequent
immunohistochemical examination for immediate early anti-
gen and early antigen revealed multiple cells with cytomega-
lovirus inclusions, thus confirming the diagnosis of CMV pan-
colitis (figure 1D). The patient immediately started receiving
gancyclovir therapy, and a perioperatively installed course of
intravenous piperacillin-tazobactam was continued for 14 days.
Serological and virological examinations 7 days after hospital
admission revealed a negative CMV PCR result, a negative CMV
IgM test result, and a CMV IgG titer of 98 IE/mL. On the day
of histopathological diagnosis of CMV pancolitis (27 days after
hospital admission), the CMV PCR result was positive (plasma
CMV RNA level, 1327 copies/mL). Twelve days later, the patient
had a positive CMV IgM test result and an IgG titer 1400 IE/
mL. These results unambiguously confirmed reactivation of
CMV disease presenting as severe ulcerous pancolitis during
primary HIV infection.
Because of the development of severe neutropenia (neutro-
phil level, 370 cells/mL) and worsening anaemia (hemoglobin
level, 8.0 g/dL), gancyclovir and zidovudine were replaced with
valgancyclovir and abacavir, respectively. Furthermore, tri-
methoprim plus sulfamethoxazole prophylaxis was replaced
with penthamidine inhalation. Again, intravenous antibiotics
(ciprofloxacin and metronidazol) were initiated until the neu-
tropenia resolved after 14 days.
Following this period, CMV disease and HIV infection were
e40 • CID 2008:46 (15 February) • BRIEF REPORT
successfully controlled, and the patient recovered rapidly. Re-
peated colonoscopic and serological monitoring has revealed
no reactivation of CMV disease to date, and the patient’s CD4
cell count increased to 932 cells/mL (with 32% neutrophils)
over a 2-year period of successful combination ART; the patient
had a constant plasma HIV RNA level !50 copies/mL.
Discussion. We report—to our knowledge for the first
time—the occurrence of acute CMV pancolitis in the context
of primary HIV infection that presented as an immune recon-
stitution inflammatory syndrome 2 weeks after initiation of
combination ART. At initial presentation to the hospital, the
patient showed a complete clinical picture of an acute retroviral
syndrome, including diarrhea, abdominal pain, fever, and
weight loss. Laboratory results revealed an increased HIV load
and massive immunosuppression (CD4 cell count, 164 cells/
mL [with 22% neutrophils]). Because other infectious and non-
infectious causes were ruled out and because almost 50% of
patients with primary HIV infection present with gastrointes-
tinal symptoms, the initial diarrhea can be attributed to primary
HIV infection. After the period of clinical improvement, the
second episode of severe diarrhea, combined with high fever
and malaise, started 2 weeks after initiation of early combi-
nation ART and was further aggravated by the occurrence of
a colon perforation demanding subtotal colectomy. Two weeks
prior to colon perforation, a colonoscopy and several biopsies
were performed. The findings of the procedures led to the
diagnosis of colitis, although CMV immunohistochemical test
results were negative at that time. Results of histopathological
examination of the biopsy specimens obtained during colec-
tomy, however, confirmed the diagnosis of acute pancolitis, and
serological tests and CMV PCR clearly confirmed CMV reac-
tivation. In aggregate, the time of events suggests that severe
immunosuppression during primary HIV infection, reflecting
profound CD4 cell depletion of gut mucosa, resulted in CMV
reactivation with subsequent pancolitis [11]. Initiation of early
combination ART subsequently led to immune reconstitution
inflammatory syndrome, and overshooting anti–CMV-specific
CD8 cell responses to the abundant CMV antigens in the colon
probably led to perforation. Occurrence of immune reconsti-
tution inflammatory syndrome is supported by the rapid de-
crease in HIV load and the rapid increase in CD4 cell count
after initiation of early combination ART (CD4 cell count, 186
cells/mL [with 37% neutrophils]; HIV RNA level, 6500 copies/
mL). The minimal increase in absolute CD4 cell count, com-
bined with a striking increase in CD4 cell percentage, should
be evaluated in the context of valganciclovir therapy, which the
patient had received for 2 weeks at that time [12].
In the literature to date, only 2 cases of acute CMV colitis
have been described in the context of primary HIV infection.
Although we present, to our knowledge, the first case of an
immune reconstitution inflammatory syndrome–associated
and reactivated severe intestinal CMV disease, Capetti et al. [3]
attributed CMV-associated hemorrhagic colitis in their patient
directly to acute HIV infection. Intense symptoms occurred
only 9 days after the diagnosis of primary HIV infection, and
the patient had a normal CD4 cell count and did not initiate
combination ART at that time. Smith et al. [4] reported a case
of CMV colitis during early HIV infection, with their patient
only retrospectively receiving a diagnosis of HIV infection. This
patient had not received combination ART, and HIV serocon-
version was suspected to have occurred ∼4 months prior to
diagnosis of CMV colitis.
In general, even though diarrhea is frequently associated with
primary HIV infection, our case demonstrates that severe CMV
colitis can present during primary HIV infection, and in rare
cases, early combination ART may result in an immune re-
constitution inflammatory syndrome.
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